Exom BioPharma, Inc.

📍 Gaithersburg, United States🗓 Founded 2022👥 4 employees💰 Last funded Jun 2022
Biotechnology Research🌐 exombiopharma.com
Website LinkedIn
Exom BioPharma has isolated a novel exosome from FDA approved food source (named as Q5 EXOSOMES) which has several technological advantages over stem cells and bovine milk derived exosomes. Exom BioPharma offers high quality research kits for exosome isolation and analysis, manufacturing highly purified exosomes from various cell lines, and animal and plant sources for research and preclinical (drug delivery) applications. Our company is also actively engaged in targeted exosome delivery research using our proprietary Q5 Exosome technology and identifying biomarkers for the early diagnosis of Pancreatic & Head and Neck Cancer and cardiovascular disease. Our company is also working towards procuring patient related biospecimen (blood, urine, saliva, CSF) and isolating cfDNA and exosomes for biomarker discovery. We are looking for R&D collaborations with research institutions and pharmaceutical companies for our Q5 Exosomes.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Exom BioPharma, Inc.?
Exom BioPharma, Inc. has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Exom BioPharma, Inc. last raise funding?
The most recent investment in Exom BioPharma, Inc. recorded on gritt.io was in June 2022.
When was Exom BioPharma, Inc. founded?
Exom BioPharma, Inc. was founded in 2022.
What industry is Exom BioPharma, Inc. in?
Exom BioPharma, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Exom BioPharma, Inc. based?
Exom BioPharma, Inc. is headquartered in Gaithersburg, United States.